ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Avalo Therapeutics Inc

Avalo Therapeutics Inc (AVTX)

12.58
0.00
(0.00%)
Closed July 23 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
12.58
Bid
12.00
Ask
13.25
Volume
-
0.00 Day's Range 0.00
3.9501 52 Week Range 71.40
Market Cap
Previous Close
12.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
26,168
Shares Outstanding
1,034,130
Dividend Yield
-
PE Ratio
-0.10
Earnings Per Share (EPS)
-30.5
Revenue
1.92M
Net Profit
-31.54M

About Avalo Therapeutics Inc

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Avalo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTX. The last closing price for Avalo Therapeutics was $12.58. Over the last year, Avalo Therapeutics shares have traded in a share price range of $ 3.9501 to $ 71.40.

Avalo Therapeutics currently has 1,034,130 shares outstanding. The market capitalization of Avalo Therapeutics is $13.01 million. Avalo Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

AVTX Latest News

Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer

WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical...

Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer

WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer. β€œWe...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.181.4516129032312.413.1912552312.74523348CS
4-0.85-6.3291139240513.4313.959210.991034712.57102966CS
12-4-24.125452352216.5817.428.91742616812.2597391CS
268.06178.3185840714.5234.464.010134824018.98802387CS
52-57.62-82.079772079870.271.43.95012319234331.96445496CS
156-676.22-98.1736353078688.81711.23.9501825186339.31340483CS
260-676.22-98.1736353078688.81711.23.9501825186339.31340483CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.162
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.91
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.51
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.35
(0.00%)
0
AACGATA Creativity Global
$ 0.65
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.162
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.91
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.51
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.35
(0.00%)
0
AACGATA Creativity Global
$ 0.65
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.162
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.91
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.51
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.35
(0.00%)
0
AACGATA Creativity Global
$ 0.65
(0.00%)
0

AVTX Discussion

View Posts
Monroe1 Monroe1 2 weeks ago
Should it dip below 10 thinking to re-enter.
πŸ‘οΈ0
gapole gapole 3 months ago
Looks like interest is coming back..16.70
πŸ‘οΈ0
Brooge warrants cancelled Brooge warrants cancelled 4 months ago
?????
πŸ‘οΈ0
Meangene818 Meangene818 4 months ago
$35 next week??
πŸ‘οΈ0
retireat40 retireat40 4 months ago
Uh…
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
AVTX over $20
Next day settlement begins 5/28 per SEC mandate
πŸ‘οΈ0
Speculator gipsy Speculator gipsy 4 months ago
Crystal ball glowing green
πŸ‘οΈ0
glens0 glens0 4 months ago
No worry what I'm hearing is more upside coming. AVTX was trading at $1130 last June.
πŸ‘οΈ0
glens0 glens0 4 months ago
Hearing a lot more coming here. Last June $1130.00 Micro Float.... 700k
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 4 months ago
#AVTX 🔥 huge move and ready for next week? $avtx
πŸ‘οΈ0
retireat40 retireat40 4 months ago
Nope
πŸ‘οΈ0
Moonboy1 Moonboy1 4 months ago
I took a chance and bought at $20. But missed a 50% profit due to no day trades left. Was hoping it would hold at least $25 for Monday. Oh well. Will be lucky to get out at $15 Monday morning in my opinion.
πŸ‘οΈ0
Pt3 Pt3 4 months ago
Same no daytrade stuck at 23
πŸ‘οΈ0
Roadtojourney Roadtojourney 4 months ago
Yes.
πŸ‘οΈ0
tonyjh tonyjh 4 months ago
Was this CERC?
πŸ‘οΈ0
Moonboy1 Moonboy1 4 months ago
I'm stuck with this until Monday at 7 am. Out of day trades so hope it holds.
πŸ‘οΈ0
gapole gapole 4 months ago
just broke 30..do i hear 35??
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
AVTX: And ya sold way too EARLY, Dude!!!
πŸ‘οΈ0
gapole gapole 4 months ago
AVTX..over 26 mvg again for ph
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 4 months ago
BCG Wow AVTX What a move!
πŸ‘οΈ0
Moonboy1 Moonboy1 4 months ago
Another holo? Congrats for the holders here. Will be interesting watching people chase this and lose their a--
πŸ‘οΈ0
Roadtojourney Roadtojourney 4 months ago
As per per, They are getting $115 million upfront payment that will go beyond 2027. And someone mentioned the float is 800k.
πŸ‘οΈ0
PennyPusher786 PennyPusher786 4 months ago
Although if you multiply by the peak price at the beginning of winter of about .25 cents... that's like $60.... and .12-.13 where it was mostly at is more like a $30 mark and a break even for many... so... I wouldn't get excited yet
πŸ‘οΈ0
PennyPusher786 PennyPusher786 4 months ago
Finally a chance to get out with sizeable returns lol... and hopefully it doesn't tank in the morning and instead runs to 30+ ahaha

πŸ‘οΈ0
apr1 apr1 4 months ago
Holy smokes! I bought 200 shares of this at 4.91 last Friday and just sold at 22.50 for a sweet 460% profit. That doesn’t happen often. 973$ to 4,500$ in 2 hours.
👍️ 3
TIMGZ TIMGZ 4 months ago
ELECTION IS COMING
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
AVTX: So there goes ALL of our trading theories, down the toilet!!! (Now it's grab them any time, & flip them any time!!!)
πŸ‘οΈ0
TIMGZ TIMGZ 4 months ago
400 PERCCEEEENT
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 months ago
AVTX: A 6-bagger for sure, even before the looming Open!!!
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Wild
πŸ‘οΈ0
surf1944 surf1944 4 months ago
https://stockcharts.com/h-sc/ui?s=avtx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/avtx/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/avtx/opinion

https://finance.yahoo.com/quote/avtx/

Short sell!
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 months ago
NO WAY

LL
πŸ‘οΈ0
Awl416 Awl416 4 months ago
Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 Million
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 months ago
$avtx 11.11 NEWS https://ir.avalotx.com/press-releases/detail/183/avalo-acquires-anti-il-1-mab-and-announces-private

https://finviz.com/quote.ashx?t=AVTX&p=d

Cash Position

The company has -2.7 months of cash left based on quarterly cash burn of -$9.3M and estimated current cash of $-8.4M.
https://dilutiontracker.com/app/search/AVTX
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
AVTX 10Qndueb3/18
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
AVTX 10Q March 11
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
AVTX 10Q March 4
πŸ‘οΈ0
oldstocks oldstocks 5 months ago
RespireRx Pharmaceuticals RSPI $ KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/
πŸ‘οΈ0
oldstocks oldstocks 5 months ago
CERECOR in September 2016 acquired right to Anti Epilepsy Drug LY3130481 from Eli Lilly Cerecor branded drug CERC-611
Cerecor and Aevi Genomic Medicine Merged Feb 2020
Cerecor rebranded into Avalo Therapeutics ticker AVTX
Avalo Therapeutics (formerly Cerecor) is developing AVTX 611 (formerly CERC 611)
November 2022 Avalo Therapeutics enters into an agreement with ES Therapeutics to sell its net economic rights to future payments of previously out-licensed assets including CERC 611
AVTX 611 got rebranded to ES 481 is being developed by ES Therapeutics for the treatment of Epilepsy.
Clinical development is underway in Australia and Canada.
Study Design
Total Participants: 24
Study Start date:
November 21, 2021
Estimated Completion Date:
December 31, 2023

This webpage mentions:
The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
https://www.sciencedirect.com/science/article/abs/pii/S000689931930410X




The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81
Abstract
The need for improved antiepileptics is clearly mandated despite the existence of multiple existing medicines from different chemical and mechanistic classes. Standard of care agents do not fully control epilepsies and have a variety of side-effect and safety issues. Patients typically take multiple antiepileptic drugs and yet many continue to have seizures. Antiepileptic-unresponsive seizures are life-disrupting and life-threatening. One approach to seizure control is surgical resection of affected brain tissue and associated neural circuits. Although non-human brain studies can provide insight into novel antiepileptic mechanisms, human epileptic brain is the bottom-line biological substrate. Human epileptic brain can provide definitive information on the presence or absence of the putative protein targets of interest in the patient population, the potential changes in these proteins in the epileptic state, and the engagement of novel molecules and their functional impact in target tissue. In this review, we discuss data on two novel potential antiepileptic drugs. CERC-611 (LY3130481) is an AMPA receptor antagonist that selectively blocks AMPA receptors associated with the auxiliary protein TARP ?-8 and is in clinical development. KRM-II-81 is a positive allosteric modulator of GABAA receptors selectively associated with protein subunits a2 and a 3. Preclinical data on these compounds argue that patient-based biological data increase the probability that a newly discovered molecule will translate its antiepileptic potential to patients.
πŸ‘οΈ0
Meangene818 Meangene818 6 months ago
May grab some today. Could be making the turn now
πŸ‘οΈ0
PennyPusher786 PennyPusher786 6 months ago
It's possible
πŸ‘οΈ0
PennyPusher786 PennyPusher786 6 months ago
Dammmmn down from $1000 in July to $5.... suddenly I have more faith in AMC lol
πŸ‘οΈ0
Meangene818 Meangene818 6 months ago
Hmmmmm!!
πŸ‘οΈ0
DeafTrader2 DeafTrader2 6 months ago
www.zacks.com STRONG BUY #1 wowza
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 7 months ago
45 Million Dollar Milestone payment and over 10 Million in cash no debt This could push cash over 50$ per share waiting for data tiny float now after massive 240 for 1 RS
πŸ‘οΈ0
m_m007 m_m007 7 months ago
Back below a dollar in 2024
πŸ‘οΈ0
colorfullife88200 colorfullife88200 7 months ago
For shareholders best interest ? tomorrow is the day ! 1 for 240 RS !!! Most wipe out , You make money by trading , they make $$ by RS ....right ?
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
Dirtbags changed ratio to 240 to 1 and moved the date to the 29th - just doesn't get much more pinkish than this group of clowns.
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
Ouchhhhheeee 250 to 1 RS tomorrow - the illusion of being a real company continues with a stolen pps increase by theft.
πŸ‘οΈ0
peanutz peanutz 7 months ago
23 million on the ask ? Really
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock